Successful response to narrow-band UVB in a patient undergoing concomitant treatment with adalimumab for psoriasis.
Lucas
Ana
A
Belinchón
Isabel
I
Pérez-Crespo
María
M
Mataix
Javier
J
Betlloch
Isabel
I
D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000532:radiotherapy*; D012720:Severity of Illness Index; D014467:Ultraviolet Therapy
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab